| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |